Sign in

    Angela Runyararo Kumirai

    Research Analyst at UBS Group

    Angela Runyararo Kumirai is an Equity Research Analyst at UBS Group, specializing in emerging markets financials with a particular focus on banks and financial institutions across Sub-Saharan Africa. She has covered leading companies such as Standard Bank Group, FirstRand, and ABSA Group, consistently providing actionable investment insights and building a strong track record for comprehensive sector analysis. Kumirai began her professional career in financial services research in 2016 and joined UBS in 2019, following analyst roles at Rand Merchant Bank and other local institutions. She holds regulatory credentials including relevant FSCA and industry certifications, and is recognized for her deep regional expertise and well-regarded institutional client coverage.

    Angela Runyararo Kumirai's questions to RxSight (RXST) leadership

    Angela Runyararo Kumirai's questions to RxSight (RXST) leadership • Q1 2025

    Question

    Angela Runyararo Kumirai of UBS Group followed up on the lack of a typical March sales ramp, asking about visibility into Q2 case schedules. She also asked for the profile of practices reporting workload challenges and how RxSight addresses the post-operative adjustment process as a perceived barrier.

    Answer

    CFO Shelley Thunen reiterated that while they have real-time data on implants, they lack visibility into future schedules, justifying the cautionary Q2 tone. President and CEO Dr. Ron Kurtz explained that concerns about workflow and the adjustment process are typical early objections to any paradigm-shifting technology, and the company has developed effective strategies and success stories to help new practices overcome these initial hurdles.

    Ask Fintool Equity Research AI